Anita Kavrakova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Mrs. Anita Kavrakova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Genetic Medico-Diagnostic Laboratory “Genica” | Bulgaria

Mrs. Anita Kavrakova is a distinguished molecular biologist and project manager with extensive experience in medical genetics and diagnostic research. Since 2019, she has been serving as Project Manager at Genetic Medico-Diagnostic Laboratory “Genica” and Genome Center Bulgaria AD in Sofia, where she oversees laboratory projects, implements innovative diagnostic techniques, ensures compliance with national and international standards, and actively contributes to scientific research through conferences, publications, and collaborative studies. Prior to this role, she worked as a Molecular Biologist at Genica (2008–2018), conducting advanced molecular analyses including PCR, qPCR, gene sequencing, and immunohistochemistry, with a focus on cancer genetics, particularly prostate and cervical cancers. She has also been a part-time assistant at the Department of Medical Chemistry and Biochemistry, Medical University Sofia, since 2012, training students in theoretical and practical biochemistry. Dr. Kavrakova earned her PhD in Genetics from Medical University Sofia in 2015, investigating molecular markers in prostate cancer for improved diagnostics and patient management, following an MS in Genetics and a Bachelor in Biology from Sofia University “St Kliment Ohridski.” She has contributed to numerous national and international research projects on infectious agents, reproductive failure, and cancer etiology, authored multiple publications, and actively participates in innovation evaluation and scientific advisory roles, demonstrating leadership, analytical skills, and a commitment to advancing molecular diagnostics and biomedical research.

Profiles : Scopus | Orcid

Featured Publications

Todorova, E., Kavrakova, A., Derimachkovski, G., Georgieva, B., Odzhakov, F., Bachurska, S., Terziev, I., Boyadzhieva, M. E., Valkov, T., Popov, E., Slavov, C., Tourtourikov, I., Mitev, V., & Todorova, A. (2025). Human Herpes Virus genotype and immunological gene expression profile in prostate cancer with prominent inflammation. International Journal of Molecular Sciences, 26(10), 4945.

Todorova, E., & Kavrakova, A., Derimachkovski, G., Georgieva, B., Kalenderova, S., Odzhakov, F., Bachurska, S., Boyadzhieva, M. E., Terziev, I., Genova, M., Mitev, V., & Todorova, A. (2025). Pathogenic contribution of human papillomaviruses and Epstein-Barr virus to prostate cancer in Bulgarian patients. C. R. Acad. Bulg. Sci. (submitted).

Mesechkova, K., Kavrakova, A., Georgieva, B., Sigridov, I., Miteva, A., Mitev, V., & Todorova, A. (2023). Bacterial and viral pathogens implicated in female reproductive failure investigated on menstrual blood. C. R. Acad. Bulg. Sci., 76(3), 394–406.

Mesechkova, K., Kavrakova, A., Georgieva, B., Sigridov, I., Mitev, V., & Todorova, A. (2023). Non-invasive diagnostics of reproductive failure with infectious etiology on menstrual tissue. Acta Medica Bulgarica, 50(3).

Mesechkova, K., Kavrakova, A., Todorova, E., Georgieva, B., Sigridov, I., Mitev, V., & Todorova, A. (2023). Role of bacterial and viral infections and co-infections in miscarriages. Acta Medica Bulgarica, 50(4).

Kavrakova, A., Todorova, A., Georgieva, B., Anachkov, K., Yanev, K., Ivanov, G., & Mitev, V. (2018). Investigation of noninvasive urine specimens with molecular fluctuations for a presence of high-risk human papilloma viruses as an inflammatory cofactor in prostate cancer. Journal of Biology and Medicine.

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2015). Molecular and clinico-histological data in aggressive prostate cancer patients from Bulgaria. JBUON, 20(2).

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2015). Molecular and clinicopathological aspects of prostate cancer in Bulgarian probands. Journal of Pathology and Oncology Research.

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2014). Molecular profile and clinicopathological aspects of prostate cancer in Bulgarian patients. Journal of BOD, 4, 18–26.

Tsvetkova, A., Kadiyska, T., Georgiev, G., Drandarska, I., Todorova, A., & Mitev, V. (2013). Molecular-genetic approach in combination with clinical and histological data for diagnostics of prostate cancer. Journal of Oncology, 3, 50–55.

 

 

Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundationreturnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications


📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025


📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025


📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025


📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025


📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016


Kalei Hering | Medicine and Dentistry | Best Researcher Award

Dr. Kalei Hering | Medicine and Dentistry | Best Researcher Award

Harvard Medical School | United States

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Kalei Hering’s academic journey began at the United States Military Academy at West Point, where she majored in Life Sciences with honors, following a pre-medical and nuclear engineering track. As a Barry Goldwater Scholar and Rhodes Scholar Finalist, her undergraduate years were marked by distinction and ambition. She then advanced to Harvard Medical School, where she pursued her M.D. with exceptional performance, scoring a 265 on the USMLE Step 2 CK and actively engaging in research and leadership.

🩺 Professional Endeavors

Currently a Resident Physician in Diagnostic Radiology at Walter Reed National Military Medical Center (expected 2030), Dr. Hering is integrating rigorous clinical training with a robust military medical background. She has held numerous leadership positions—from Platoon Leader to President of Harvard’s Interventional Radiology Interest Group—reflecting a rare blend of military discipline and medical acumen. Her clinical and surgical experiences at institutions like Walter Reed, MGH, and BIDMC have laid a strong foundation for a future in academic and interventional radiology.

🔬 Contributions and Research Focus

Dr. Hering’s research spans vascular and interventional radiology, pulmonary arteriovenous malformations, trauma imaging, and military health, with over 20 peer-reviewed publications. She has contributed to top-tier journals including CHEST, Spine Journal, Journal of Vascular and Interventional Radiology, and Military Medicine. As an editor for the MGH “White Book”, she has also shaped essential medical manuals for house staff. Her passion for research was recognized early through internships and fellowships, including work on Lyme disease and steroid hormone physiology.

🏅 Accolades and Recognition

A decorated scholar and athlete, Dr. Hering has earned numerous honors including:
🏆 1897 Fellowship Awardee (Top national Phi Kappa Phi applicant)
🥇 Trainee Case Competition Winner, New England Society of Interventional Radiology
🏃‍♀️ Champion in multiple marathons and ultramarathons including the Candlelight 12-Hour and Spartan Race
🎖️ Excellence in Life Science Award, Brigadier General Ramsden Award, and LTC Boyd Harris Leadership Award at West Point
📚 Recognized by the West Point Superintendent for academic, military, and physical excellence

🌍 Impact and Influence

Dr. Hering is a changemaker in both academic medicine and military health systems. Her efforts to increase access and mentorship—such as developing shadowing programs, founding wellness initiatives, and mentoring underrepresented pre-med students—demonstrate her commitment to building inclusive, high-impact medical communities. Her involvement in the Society of Interventional Radiology, Excelsior Surgical Society, and Empower Conference reflects a strategic vision for the future of healthcare delivery, particularly in military and interventional contexts.

🔮 Legacy and Future Contributions

With a rare combination of military leadership, scientific rigor, and clinical excellence, Dr. Kalei Hering is poised to leave a lasting mark on the fields of interventional radiology, medical education, and military medicine. Her pursuit of innovative techniques, policy development, and mentorship ensures that her influence will be deeply felt across clinical, academic, and operational environments for years to come. As she advances through her residency and beyond, Dr. Hering stands as a beacon of resilience, intellect, and service in modern medicine.

Publications


📄 Post-Treatment Monitoring of Pulmonary Arteriovenous Malformations: Challenges and Approaches

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: CHEST

  • Year: 2025


📄 Embolization of a Bleeding Duodenal Arteriovenous Malformation with a Conformable Embolic Material (Obsidio): Case Report

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: Journal of Clinical Interventional Radiology ISVIR

  • Year: 2025


📄 Long-Term Quality of Life and Functional Outcomes After Management of Spinal Epidural Abscess

  • Authors:  Kalei Hering, Grace X. Xiong, Andrew Nguyen, Andrew J. Schoenfeld

  • Journal:  The Spine Journal

  • Year: 2024


📄 Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

  • Authors: Kalei Hering, Miles W.A. Fisher, Michael K. Dalton, Andrew K. Simpson, Jamie Ye, Nishant Suneja, Zara Cooper, Tracey P. Koehlmoos, Andrew J. Schoenfeld

  • Journal: Journal of Bone and Joint Surgery

  • Year: 2022


 

Subhash Chandra Yadav | Health Professions | Best Researcher Award

Prof. Dr. Subhash Chandra Yadav | Health Professions | Best Researcher Award

All India Institute of Medical Sciences, New Delhi | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits 🎓

Prof. Dr. Subhash Chandra Yadav began his academic journey with an MSc in Biotechnology from Banaras Hindu University (BHU), Varanasi, in 2003. His thirst for knowledge led him to pursue a Ph.D. in Molecular Biology at BHU, which he completed in 2007 under the mentorship of Prof. Jagannadham V. Medicherla. His doctoral research focused on "Milin," a highly stable glycosylated dimeric plant serine protease from Euphorbia milii, examining its structure, function, folding, and crystallographic properties. During his academic development, he also gained international exposure as a research trainee at the Institute of Crystallography, Free University (FU) Berlin, Germany, from September 2005 to April 2006, where he honed his skills in protein structural biology.

Professional Endeavors and Milestones 💼

Dr. Yadav's illustrious career spans prestigious institutions globally:

  • Postdoctoral Fellowships: He worked on molecular biophysics at the Indian Institute of Science (IISc), Bangalore, and at the Graduate School of Medicine, University of Tennessee, USA.
  • Research and Leadership Roles: As a Scientist and In-Charge of Nanobiology and Electron Microscopy Facility at CSIR-IHBT, Palampur, and Fellow at TERI-Deakin Nanobiotechnology Centre, he spearheaded cutting-edge research.
  • Academic Excellence: He has been serving All India Institute of Medical Sciences (AIIMS), New Delhi, since 2015, rising to the role of Additional Professor. He was also a Visiting Professor at Stanford University, USA, in 2019-2020.

Contributions and Research Focus 🔬

Dr. Yadav’s research interests are at the confluence of nanotechnology, molecular biology, and microscopy:

  • Electron Microscopy and Cryo-Electron Tomography: Advancing the understanding of cellular structures at atomic resolution.
  • Nano-enabled Diagnostic Tools: Innovating methods for rapid and accurate disease detection.
  • Targeted Drug Delivery Systems: Developing nanoparticles for precise therapeutics.

His work includes over 6,630 citations, with an h-index of 18, reflecting the impact of his research. His patent portfolio includes innovative detection kits, cancer diagnostics, and nanotechnology-based systems.

Accolades and Recognition 🏆

Dr. Yadav's groundbreaking contributions have earned him numerous accolades:

  • 2024: Fellow of the Electron Microscopy Society of India.
  • 2019: Long-Term Fellowship from the Department of Health Research to work at Stanford University.
  • 2018: Excellence in Microscopy Award by the Electron Microscope Society of India.
  • 2005-2006: Boehringer Ingelheim Fonds Fellowship, Germany.

Impact and Influence 🌍

Dr. Yadav has significantly influenced the fields of nanotechnology and microscopy through his teaching, research, and mentorship. As a member of prestigious societies like the Indian Biophysical Society and a reviewer for leading journals, he has contributed to advancing scientific knowledge. His innovative patents and publications continue to inspire advancements in diagnostics and therapeutics.

Legacy and Future Contributions Highlight 🚀

With a career defined by scientific rigor, international collaboration, and a vision for impactful research, Dr. Yadav stands as a beacon of innovation. His ongoing work in nanotechnology and cryo-electron tomography promises to shape the future of medical diagnostics and targeted therapies, leaving a lasting legacy in science and technology.

 

Publications


📄 Magnetic nanoparticles and quantum dots coupled immuno nano fluorescence assay for visual detection of HPV16-induced cervical cancer cells from cytology/biopsy samples
Authors: Raman, S., Tanwar, P., Meena, J., Bhatla, N., Yadav, S.C.
Journal: Sensing and Bio-Sensing Research
Year: 2024


📄 Genetics of 67 patients of suspected primary ciliary dyskinesia from India
Authors: Jat, K.R., Faruq, M., Jindal, S., Arava, S.K., Kabra, S.K.
Journal: Clinical Genetics
Year: 2024


📄 Quantitative and qualitative analysis of metallic ion release of orthodontic brackets in three different pH conditions - An invitro study
Authors: DA, P., Angel L, S., Chaudhari, P.K., Yadav, S.C., Duggal, R.
Journal: Journal of Oral Biology and Craniofacial Research
Year: 2024


📄 Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis
Authors: Gaur, P., Rajendran, Y., Srivastava, B., Ahuja, V., Srikanth, C.
Journal: eLife
Year: 2024


📄 Visual, rapid, and cost-effective BK virus detection system for renal transplanted patients using gold nanoparticle coupled loop-mediated isothermal amplification (nanoLAMP)
Authors: Kumar, S., Raman, S., Sesham, K., Mridha, A.R., Yadav, S.C.
Journal: Journal of Virological Methods
Year: 2024


 

Elif Keskin Bilgiç | Engineering | Best Researcher Award

Mrs. Elif Keskin Bilgiç | Engineering | Best Researcher Award

Istanbul University -Cerrahpaşa | Turkey

Author Profile

Orcid

Early Academic Pursuits 🎓

Mrs. Elif Keskin Bilgiç's academic journey began with a strong foundation in biology, earning her B.Sc. in Biology from Abant İzzet Baysal University in 2010. She further pursued her passion for biomedical engineering, completing an M.Sc. at Istanbul University in 2016. Her master's thesis focused on investigating the therapeutic effects of innovative biomaterials, such as L-Dopa and Lawsone, in wound healing. This early academic focus laid the groundwork for her expertise in biomedical engineering and clinical applications. In 2024, she completed her Ph.D. in Biomedical Engineering from Istanbul University-Cerrahpaşa, specializing in non-invasive clinical decision support systems for diagnosing gastrointestinal diseases using advanced machine learning methods. 📚

Professional Endeavors 💻

With over a decade of professional experience, Mrs. Bilgiç has made significant contributions as both a researcher and educator. She has taught Cambridge Biology at the A-Level from 2016 to 2024 at the International Gokkusagi School in Istanbul, equipping students with critical knowledge to excel in international examinations. As a researcher at Istanbul University-Cerrahpaşa since 2016, she has pioneered research using transfer learning techniques to detect celiac disease, developing predictive machine learning models to aid in diagnostics. Her work in wound healing and biomaterials during her early career helped shape her innovative approaches in biomedical engineering.

Contributions and Research Focus 🔬

Mrs. Bilgiç's research centers on developing non-invasive clinical decision support systems for diagnosing autoimmune diseases, with a particular focus on celiac disease. Her groundbreaking research involves the use of machine learning models, including transfer learning and deep learning, to diagnose the disease by analyzing facial images and predicting Marsh levels from patient data. This innovative approach merges cutting-edge AI technology with clinical diagnostics, advancing the field of medical science. In addition, her research on the therapeutic effects of biomaterials in wound healing has expanded the knowledge base in biomedical engineering.

Accolades and Recognition 🏆

Mrs. Bilgiç has published multiple scientific papers, including an original article on using transfer learning for celiac disease identification, which has garnered attention within the scientific community. Her work has been presented at numerous conferences and symposia, including international venues such as the Bilge Kagan 2nd International Science Congress in Barcelona, Spain, and the 11th Nanoscience and Nanotechnology Conference in Ankara, Turkey. Her innovative approaches to clinical diagnostics and contributions to autoimmune disease research have earned her recognition as a thought leader in the field.

Impact and Influence 🌍

Through her research, Mrs. Bilgiç is reshaping how clinical diagnostics are performed, particularly for gastrointestinal and autoimmune diseases. Her development of non-invasive diagnostic systems could revolutionize patient care, offering faster and more accurate diagnosis options. Her educational impact extends beyond the research lab, as she has inspired countless students through her teaching, blending her academic and professional expertise into practical applications that shape future scientists and researchers.

Legacy and Future Contributions ✨

Mrs. Bilgiç's work in machine learning, biomedical engineering, and education has laid a strong foundation for future advancements in healthcare technology. Her legacy will likely be marked by her innovations in non-invasive diagnostic tools and her contribution to the understanding of biomaterials in medical treatment. As her research evolves, she is poised to continue making significant contributions that will benefit patients and healthcare providers alike, influencing the future of clinical decision support systems and biomedical engineering for years to come.

 

Publications


📖 Innovative Approaches to Clinical Diagnosis: Transfer Learning in Facial Image Classification for Celiac Disease Identification 
Author: Elif Keskin Bilgiç, Inci Zaim Gokbay, Yusuf Kayar
Journal: Applied Sciences
Year: 2024